Optimizing Fluid Management Guided by Volumetric Parameters in Patients with Sepsis and ARDS

Area of Science:

• Critical Care Medicine
• Pulmonary Medicine
• Emergency Medicine

Background:

• Sepsis and Acute Respiratory Distress Syndrome (ARDS) are critical conditions often requiring fluid management.
• Optimizing fluid therapy is crucial for patient outcomes in sepsis-induced ARDS.
• De-escalation of fluid therapy aims to reduce fluid overload and improve respiratory mechanics.

Purpose of the Study:

• To compare two de-escalation strategies for fluid therapy in patients with sepsis and ARDS.
• To evaluate the efficacy of extravascular lung water index (EVLWI) versus global end-diastolic volume index (GEDVI) guided de-escalation.
• To assess the impact on oxygenation, lung fluid balance, and organ dysfunction.

Main Methods:

• A randomized controlled trial involving 60 patients with sepsis and ARDS.
• Patients were assigned to fluid de-escalation guided by either EVLWI (n=30) or GEDVI (n=30).
• Diuretics or ultrafiltration were used to achieve a negative fluid balance when GEDVI > 650 mL/m² or EVLWI > 10 mL/kg.

Main Results:

• Both strategies led to a decrease in SOFA scores and improved arterial oxygenation (PaO2/FiO2).
• EVLWI-guided therapy significantly reduced extravascular lung water and showed a greater increase in PaO2/FiO2 (30% vs 15%).
• Patients with direct ARDS responded better to dehydration therapy regarding oxygenation and lung fluid balance.

Conclusions:

• Both EVLWI and GEDVI-guided de-escalation strategies are effective in improving outcomes for sepsis-induced ARDS.
• EVLWI-guided de-escalation appears more efficient in reducing lung fluid and improving oxygenation, particularly in direct ARDS.
• De-escalation therapy is beneficial for managing fluid balance and organ dysfunction in sepsis and ARDS.